Water → 3-[((3S)-3-Methyl-4-{[4-(trifluoromethyl)phenyl]sulfonyl}-1-piperazinyl)carbonyl]pyrazolo[1,5-a]pyrimidine
反応式
Cl.[CH3:2][C@H:3]1[CH2:8][NH:7][CH2:6][CH2:5][N:4]1[S:9]([C:12]1[CH:17]=[CH:16][C:15]([C:18]([F:21])([F:20])[F:19])=[CH:14][CH:13]=1)(=[O:11])=[O:10].C1C=CC2N(O)N=NC=2C=1.O.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[N:57]1[N:61]2[CH:62]=[CH:63][CH:64]=[N:65][C:60]2=[C:59]([C:66](O)=[O:67])[CH:58]=1.CCN(C(C)C)C(C)C>C1COCC1>[CH3:2][C@@H:3]1[N:4]([S:9]([C:12]2[CH:13]=[CH:14][C:15]([C:18]([F:21])([F:19])[F:20])=[CH:16][CH:17]=2)(=[O:11])=[O:10])[CH2:5][CH2:6][N:7]([C:66]([C:59]2[CH:58]=[N:57][N:61]3[CH:62]=[CH:63][CH:64]=[N:65][C:60]=23)=[O:67])[CH2:8]1参加物
反応物 6
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of (2S)-2-methyl-1-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine hydrochloride (may be prepared as described in Description 6) (100 mg, 0.270 mmol) in THF (5 ml) was added HOBT.H2O (41.3 mg, 0.270 mmol), HBTU (102 mg, 0.270 mmol) and pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (48.4 mg, 0.297 mmol). The mixture was stirred for 5 minutes before addition of DIPEA (0.118 ml, 0.674 mmol) and the resultant solution stirred at rt for 16 hours. The mixture was then concentrated and the residue partitioned between DCM (10 ml) and water (10 ml), the layers were separated using a hydrophobic frit and the organic layers concentrated to dryness and the crude material dissolved in DMSO and purified by MDAP to give the title compound (85.3 mg) as a white solid.
後処理
- concentrationThe mixture was then concentrated
- customthe residue partitioned between DCM (10 ml) and water (10 ml)
- customthe layers were separated
- concentrationthe organic layers concentrated to dryness
- dissolutionthe crude material dissolved in DMSO
- custompurified by MDAP
出典と根拠
- ORDレコード
- ord-eb0845f86c284cd9b0afbedca2514b98
- 出典データセット
- uspto-grants-2012_01
- 特許番号
- US08093249B2
反応ノート
読み込み中…